Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 280
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction...
Psilocybin Data Study Agreement Reached Between Silo Wellness and Ehave Using...
Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and...
Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies
Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics...
COMPASS Pathways granted two US patents
Mydecine Innovations Group Announces Migration to NEO Exchange
PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic
Psychedelic Synesthesia: Smell That Tune
Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation...
Load more